CIK 0001321834 · Non-accelerated filer<br>Smaller reporting company
Q/C TECHNOLOGIES, INC.
Sign in to watch- Ticker
- QCLS
- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 856-848-8698
- Business address
- 1185 AVENUE OF THE AMERICAS, SUITE 249, NEW YORK, NY, 10036
- Former names
- Q/C TECHNOLOGIES, INC., TNF Pharmaceuticals, Inc., MyMD Pharmaceuticals, Inc., Akers Biosciences, Inc., Akers Biosciences Inc
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-04-16 | Uzonwanne Jude Director | Grant or award · Stock Option (Right to Buy) | +115,770 | 115,770 | ||
| 2021-04-16 | Chapman Christopher C JR President, Chief Med. Officer | Grant or award | +96,475 | 96,475 | ||
| 2021-04-16 | Chapman Christopher C JR President, Chief Med. Officer | Grant or award · Stock Option (Right to Buy) | +38,590 | 38,590 | ||
| 2021-04-16 | Chapman Christopher C JR President, Chief Med. Officer | Grant or award · Stock Option (Right to Buy) | +77,180 | 77,180 | ||
| 2021-04-16 | Chapman Christopher C JR President, Chief Med. Officer | Grant or award · Stock Option (Right to Buy) | +77,180 | 77,180 | ||
| 2021-04-16 | Chapman Christopher C JR President, Chief Med. Officer | Grant or award · Stock Option (Right to Buy) | +96,475 | 96,475 | ||
| 2021-04-16 | Rivard Paul EVP of Operations, GC | Grant or award · Stock Option (Right to Buy) | +77,180 | 77,180 | ||
| 2021-04-16 | Rivard Paul EVP of Operations, GC | Grant or award · Stock Option (Right to Buy) | +77,180 | 77,180 | ||
| 2021-04-16 | SCHROEDER ROBERT C Director | Option exercise | +43,930 | 43,930 | ||
| 2021-04-16 | SCHROEDER ROBERT C Director | Shares withheld for taxes | −14,694 | $4.94 | $73K | 29,236 |
| 2021-04-16 | SCHROEDER ROBERT C Director | Option exercise · Restricted Stock Units | −43,930 | 0 | ||
| 2021-04-16 | Silverman Joshua Director | Option exercise | +109,500 | 112,101 | ||
| 2021-04-16 | Silverman Joshua Director | Shares withheld for taxes | −38,325 | $4.94 | $189K | 71,175 |
| 2021-04-16 | Silverman Joshua Director | Option exercise · Restricted Stock Units | −109,500 | 0 | ||
| 2021-04-16 | White Billy Joe Director | Option exercise | +109,500 | 112,101 | ||
| 2021-04-16 | White Billy Joe Director | Shares withheld for taxes | −38,325 | $4.94 | $189K | 71,175 |
| 2021-04-16 | White Billy Joe Director | Option exercise · Restricted Stock Units | −109,500 | 0 | ||
| 2020-09-11 | White Billy Joe Director | Grant or award · Restricted Stock Unit | +219,000 | 219,000 | ||
| 2020-09-11 | Silverman Joshua Director | Grant or award · Restricted Stock Unit | +219,000 | 219,000 | ||
| 2020-09-11 | SCHROEDER ROBERT C Director | Grant or award · Restricted Stock Unit | +87,860 | 87,860 |
Page 4 of 8 · 142 trades